SCHEMBL14414761

SCHEMBL14414761

COCC1O[C@@H](C)[C@@H](C)C(C)[C@H]1OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18893455 1.00 — —
SCHEMBL18294595 0.83 FGF1 (0.33) —
SCHEMBL25594518 0.83 FGF1 (0.33) —
SCHEMBL25594520 0.83 FGF1 (0.33) —
SCHEMBL19051014 0.83 FGF1 (0.33) —
SCHEMBL25605193 0.83 FGF1 (0.33) —
SCHEMBL18755374 0.81 FGF1 (0.36) —
SCHEMBL12441863 0.81 FGF1 (0.36) —
SCHEMBL9908979 0.81 SPHK1 (0.30) —
SCHEMBL18755371 0.81 FGF1 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219161-A1 Preparation Process Of Oligoglycosaminoglycan, And Reducing End Glucuronic Acid Type Oligochondroitin Sulfate And Pharmaceutical Composition Comprising The Same TAISHO PHARMACEUTICAL CO., LTD (JP) 2007-09-20 — — US disclosed
Send feedback